PREBIOTIC CASE STUDY RESULTS & RATIONALEDr. Bill Misner PhD[1] ABSTRACT Endurance athletes periodically report a myriad of intestinal disorders related to the lack of both beneficial probiotic strains and prebiotics to regenerate healthy gut flora colonization. Coupled with American diets, chlorinated water, gastrointestinal exposure to antibiotics, or harmful bacteria from food chain, inadequate soluble and insoluble fiber, there is no wonder why gastrointestinal issues result from poor deficient microflora populations. A 69-year male endurance athlete & 56-year female non-athlete consumed a supplement containing 7-grams fiber with a prebiotic daily for 30-days to determine if "Prebiotin" had a positive effect on bowel health and reducing cholesterols. These subjects reported increased flatulence for the first 5-days that gradually subsided. Improved bowel movement and less flatulence occurred following 25-days dose with no negative side effects. Subjects represent considerable differences, one, a male endurance athlete with healthy-low normal cholesterol levels and a female non-athlete with elevated cholesterol levels. The male endurance athlete followed a vegetarian diet lifestyle and he thought his cholesterol levels were as low as they could go. The sedentary female followed a mixed nutritional foods selected, some that cause elevated cholesterol and some from plant food fibers that reduce cholesterol. The female presents high cholesterol that should be decreased, while the male presents cholesterol levels that were less likely to be reduced by dietary alterations. Both subject's cholesterols were determined prior to consuming this "Prebiotin" prebiotic fiber daily for a 30-day trial period. The pre-test values are compared to the post-30 day trial values:
NECESSITY FOR BENEFICIAL BACTERIA BALANCEBeneficial bacteria in the colon convert cholesterol to coprostanol for excretion, thereby lowering total serum cholesterol levels. Various species of beneficial bacteria (as well as various species of potentially detrimental bacteria) populate the colon. The total number of species of bacteria in the colon is approximately 400. It is estimated that bacteria account for 30-50% of the volume of the contents of the colon. In the colon, beneficial bacteria ferment insoluble fiber, starch and undigested carbohydrates. The short-chain saturated fatty acids produced by this fermentation are the principal source of energy for the epithelial cells of the colon. Beneficial flora reside in the intestines and may manufacture some vitamins such as Biotin, Choline, Folic Acid, Inositol, PABA (Para Aminobenzoic Acid), Vitamin B2, Vitamin B5, Vitamin B6, & Vitamin K. Beneficial bacteria in the large intestine cause fermentation of dietary carbohydrates (especially polysaccharides) that results in the production of volatile fatty acids including acetic acid, butyric acid and propionic acid. Beneficial bacteria balance has been proposed to prevent or resolve constipation, gastroenteritis, urinary tract infections (UTIs), irritable bowel syndrome, instestinal cramps, abdominal pain, ulcerative colitis, and flatulence. Beneficial bacteria enhance the general health of the digestive system and strengthen the immune system functions of the intestines. Beneficial bacteria produce hydrogen peroxide utilized by the body to “extinguish” neutralized antigen/antibody complexes in order to produce substances such as acetic acid, bacteriocins, lactic acid and hydrogen peroxide to counteract a detrimental bacteria and viruses. Without intestinal flora balance between good bacteria and detrimental flora, imbalances result that may inhibit both health and endurance performance...
GUT BACTERIAL IMBALANCESExcessive consumption of chlorine may destroy beneficial bacteria. Pharmaceutical antibiotics such as tetracycline (when ingested orally) may destroy the body's beneficial bacteria - as a side effect of their primary purpose of killing detrimental bacteria. Excessive quantities of detrimental bacteria within the digestive tract may "crowd out" beneficial bacteria. Huis Veld [1991] reported, that a balanced and stable gastro-intestinal microflora is of vital importance for the optimum function of the gastro-intestinal tract and consequently for the health of man and animals. In addition it has a positive effect on nutrition (digestion, effects on physiology, production of vitamins). Intestinal flora has a protective function (prevention of infection). Changes in diet, stress, the use of antibiotics and excessive hygiene all bring about changes in the microbiological ecosystem and consequently negates compromise in health. Recently, increasing attention is being paid to the development of methods to influence the composition of the gastro-intestinal microflora in man and animals by probiotics (dried cells or fermented food).[i]
STRESS INCREASES HARMFUL BACTERIAKelly et al., [1999] examined the impact of high stress on intestinal microflora during the preparation for and participation in space flight. During the preparation phase the authors found a distinct decrease in the numbers of Bifidobacterium and Lactobacilli, and a corresponding increase in the numbers of E. coli and of Enterobacteria. These imbalances worsened until launch, illuminating the effect of nervous-emotional stress on altering the balance of beneficial and pathogenic organisms. After the flight the number of potentially pathogenic Enterobacteria and Clostridia were also substantially increased, while the number of Lactobacilli was decreased, suggesting the physiological stress of space flight disrupted microflora balance.[ii] . CARCINOGEN POTENTIALMoore et al., [1978] quantitative studies of the fecal flora of populations at different risk of colon cancer indicate that the relative proportions of some particular species of bacteria rather than of different genera of bacteria may be correlated with colon cancer incidence. The bacteria in feces do reflect the flora of the large colon. The composition of the flora was not significantly affected by drastic changes in diet, but statistically significant shifts in the proportions of some species were noted in individuals under conditions of anger or fear stress. Although diet may not change the flora the individual maintains, the bacteria present may convert the different substrates provided by a high-fat diet as opposed to a high-fiber diet into metabolites that are potentially carcinogenic. The conversion of dietary components to carcinogenic compounds, identification of the bacteria capable of effecting such conversions, and the conditions favoring the proliferation of such bacteria will be investigated in greater detail.[iii]
INULIN-ENRICHED FRUCTOOLIGOSACCHARIDES [FOS]Fructooligosaccharides are a group of (non-digestible) Oligosaccharides [FOS] composed of short-chain polymers of Fructose. They are composed of one molecule of Sucrose and one to three molecules of Fructose. Fructooligosaccharides are produced either through fermentation by enzymes produced by the Fungus Aspergillus niger acting on Sucrose (the resulting product is known as Neosugar) or by the enzymatic hydrolysis of Inulin. FOS have been shown to produce the following gastrointestinal effects:
OAT BRANOat Bran, Avena sativa, is the outer husk of oat grains. Oat Bran is not only the highest dietary source of insoluble fiber, but it is balanced 50% soluble to 50% insoluble fiber by analysis, presenting all the benefits from both forms of fiber in one unit.
Oat bran's benefits in human health are reported to:
PSYLLIUMPsyllium is a type of Hemicellulose Mucilage - a mixed Polysaccharide composed of a Xylan backbone linked with Xylose, Arabinose, Galacturonic Acid and Rhamnose. The potential health benefits from psyllium as a prebiotic bowel health supplement are:
CONCLUSION Two subjects one with low-normal healthy cholesterol and one with elevated cholesterol taking “Prebiotin” probiotic-fiber supplement daily significantly lowered cholesterol levels both unexpectedly -6% and -22% respectively in only 30 days time. DISCLOSURE STATEMENT The author declares no competing interests past, present, or future from sales of this product, Prebiotin. The product selected for this case study trial was supplied courtesy of the manufacturer, Jackson GI Medical, 200 Grandview Ave., Camp Hill, PA 17011, 888-320-5030. All content copyright 2010 by Dr. Bill Misner, PhD. All Rights Reserved. Used by Jackson GI Medical Co. with kind permission of Dr. Misner.
[1] AAMA Board Certified Alternative Medicine Practitioner Director (Emeritus) Research & Product Development Hammer Nutrition, Whitefish, Montana USA (800) 336-1977 http://www.hammernutrition.com/za/HNT?PAGE=KNOWLEDGE [i] Huis Veld, J. H. [Gastrointestinal flora and health in man and animal.] Tijdschr Diergeneeskd. 116(5):232-239, 1991. [ii] Kelly, G. S. Nutritional and botanical interventions to assist with the adaptation to stress. Alternative Medicine Review. 4(4):249-265, 1999. [iii] Moore, W. E., et al. Some current concepts in intestinal bacteriology. Am J Clin Nutr. 31(10 Supplement):S33-S42, 1978. [iv] Lindsay, J. O., et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut. 55(3):348-355, 2006. [v] Martin, S. Intestinal permeability. BioMed Newsletter. 11, 1995.This occurs from the hydrolyzation and fermentation of FOS by Bifidobacteria to produce Acetic Acid and Lactic Acid. This Lactic Acid is then further metabolized by other Beneficial Bacteria to form Butyric Acid and Propionic Acid. This Butyric Acid enhances the function of the Intestinal Wall. [vi] Taper, H. S., et al. Influence of inulin and oligofructose on breast cancer and tumor growth. Journal of Nutrition. 129(Supplement):1488S-1491S, 1999 & Taper, H. S., et al. Inulin/oligofructose and anticancer therapy. Br J Nutr. 87(Supplement 2):S283-S286, 2002. [vii] Tomomatsu, H. Health effects of oligosaccharides. Food Technology. October 1994:61-65. [viii] Fiordaliso, M., et al. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids. 30:163-167, 1995. [ix] Hosona, A., et al. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells. Biosci Biotechnol Biochem. 67(4):758-764, 2003. [x] Tomomatsu, H. Health effects of oligosaccharides. Food Technology. October 1994:61-65. [xi] Buddington, R. K., et al. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. American Journal of Clinical Nutrition. 63(5):709-716, 1996 Full text of this study can be viewed at: www.ajcn.org/cgi/reprint/63/5/709 [xii] Howard, M. D., et al. Dietary fructooligosaccharide, xylooligosaccharide and gum arabic have variable effects on cecal and colonic microbiota and epithelial cell proliferation in mice and rats. Journal of Nutrition. 125(10):2604-2609, 1995 Full text of this study can be viewed at: http://jn.nutrition.org/cgi/reprint/125/10/2604 Howard, M. D., et al. Effects of dietary supplementation with fructooligosaccharides on colonic microbiota populations and epithelial cell proliferation in neonatal pigs. J Ped Gast Nutr. 21(3):297-302, 1995. [xiii] Bouhnik, Y., et al. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans. Nutrition Journal. 5:8, 2006. Full text of this study can be viewed at: www.nutritionj.com/content/5/1/8 Buddington, R. K., et al. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. American Journal of Clinical Nutrition. 63(5):709-716, 1996. Gibson, G. R., et al. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr. 125:1401-1412, 1995. Gibson, G. R., et al. Selective stimulation of bifidobacteria in the human colony by oligofructose and inulin. Gastroenterology. 108:975-982, 1995. Gibson, G. R., et al. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. Microbiol Lett. 118:121-128, 1994. Hidaka, H., T., et al. Effects of Fructo-oligosaccharides on intestinal flora and human health. Bifidobacteria Microflora. 5(1):37050, 1986. Hidaka, H. Y., et al. Proliferation of bifidobacteria by oligosaccharides and their useful effect on human health. Bifidobacteria Microflora. 10(1): 65-79, 1991. Howard, M. D., et al. Dietary fructooligosaccharide, xylooligosaccharide and gum arabic have variable effects on cecal and colonic microbiota and epithelial cell proliferation in mice and rats. J Nutr. 125:2604-2609, 1995. Howard, M. D., et al. Effects of dietary supplementation with fructooligosaccharides on colonic microbiota populations and epithelial cell proliferation in neonatal pigs. J Ped Gast Nutr. 21(3):297-302, 1995. McKellar, R. C., et al. Metabolism of fructo-oligosaccharides by Bifidobacterium spp. Applied Micro-Biotechnology. 31: 537-541, 1989. Mitsuoka, T., et al. Effect of fructo-oligosaccharides on intestinal flora. Die Nahrung. 31:5-6, 427-436, 1987.] [xiv] Loboa, A. R., et al. Fructooligosaccharides improve bone mass and biomechanical properties in rats. Nutrition Research. 26(8):413-420, 2006. Zafar, T. A., et al. Nondigestible oligosaccharides increase calcium absorption and suppress bone resorption in ovariectomized rats. Journal of Nutrition. 134(2):399-402, 2004. [xv] Tahiri, M., et al. Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. Journal of Bone and Mineral Research. 16:2152-2160, 2001. [xvi] He, J., et al. Effect of dietary fiber intake on blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens. 22(1):73-80, 2004. [xvii] Miller, A. L. The pathogenesis, clinical implications, and treatment of intestinal hyperpermeability. Alternative Medicine Review. 2(5):330-345, 1997. [xviii] Berg, A., et al. Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study. Ann Nutr Metab. 47(6):306-311, 2003. Brown, L., et al. Cholesterol-lowering effects of dietary fiber: a meta-analysis. American Journal of Clinical Nutrition. 69(1):30-42, 1999. Gerhardt, A. L., et al. Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans. Journal of Nutrition. 128(5):865-869, 1998. Gold, K. V., et al. Oat bran as a cholesterol-reducing dietary adjunct in a young healthy population. Western Journal of Medicine. 148:299-302, 1988. Keenan, J. M., et al. Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: A pilot trial. J Fam Pract. 51(4):369, 2002. Kelley, M., et al. Oat bran lowers total and low-density lipoprotein cholesterol but not lipoprotein (a) in exercising adults with borderline hypercholesterolemia. Journal of the American Dietetic Association. 94(12):1419- 1421, 1994. [xix] Weickert, M. O., et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care. 29(4):775-780, 2006. [xx] Bridges, S. R., et al. Oat bran increases serum acetate of hypercholesterolemic men. American Journal of Clinical Nutrition. 56(2):455-459, 1992 & Miller, A. L. The pathogenesis, clinical implications, and treatment of intestinal hyperpermeability. Alternative Medicine Review. 2(5):330-345, 1997. [xxi] Marlett, J. A., et al. Mechanism of serum cholesterol reduction by oat bran. Hepatology. 20(6):1450-1457, 1994. [xxii] . Ho. Y. H., et al. Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids: randomized controlled trial. Dis Colon Rectum. 43(1):66-69, 2000. [xxiii] Burke, V., et al. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension. 38(4):821-826, 2001. [xxiv] Blackwood, A. D., et al. Dietary fibre, physicochemical properties and their relationship to health. J R Soc Health. 120(4):242-247, 2000. [xxv] Marlett, J. A., et al. An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans. Am J Clin Nutr. 72(3):784-789, 2000. [xxvi] Sherman, D. S., et al. Management of protease inhibitor-associated diarrhea. Clin Infect Dis. 30(6):908-914, 2000. [xxvii] Fujimori, S., et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. J Gastroenterol Hepatol. 22(8):1199-1204, 2007. [xxviii] Werth, S., et al. Influence on symptoms and transit-time of Vi-SiblinR in diverticular disease. Acta Chir Scand Suppl. 500:49–50, 1980. [xxix] Zaman, V., et al. The presence of antiamoebic constituents in Psyllium husk. Phytotherapy Research. 16(1):78-79, 2002. [xxx] Moran, S., et al. [Effects of fiber administration in the prevention of gallstones in obese patients on a reducing diet. A clinical trial.] Rev Gastroenterol Mex. 62(4):266-272, 1997. [xxxi] Moran, S., et al. [Effects of fiber administration in the prevention of gallstones in obese patients on a reducing diet. A clinical trial.] Rev Gastroenterol Mex. 62(4):266-272, 1997. [xxxii] Fernandez-Banares, F., et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol. 94(2):427-433, 1999. [xxxiii] Cohen, L. A., et al. Wheat bran and psyllium diets: effects on N-methylnitrosourea-induced mammary tumorigenesis in F344 rats. Journal of the National Cancer Institute. 88(13):899-907, 1996. Cheng, Y., et al. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice. Br J Nutr. 91(5):715-723, 2004. [xxxiv] Hayden, U. L., et al. Psyllium improves fecal consistency and prevents enhanced secretory responses in jejunal tissues of piglets infected with ETEC. Dig Dis Sci. 43(11):2536-2541, 1998. [xxxv] Petchetti, L., et al. Nutriceuticals in cardiovascular disease: psyllium. Cardiol Rev. 15(3):116-122. 2007. Kumar, A., et al. A comparative evaluation of ispaghula husk (dietary fiber) and simvastatin in hyperlipidemic indian patients. Indian Heart Journal. 54(5), 2002. Abel, E., et al. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Archives of Internal Medicine. 165(10):1161-1166, 2005. [xxxvi] Hannan, J. M., et al. Aqueous extracts of husks of Plantago ovata reduce hyperglycaemia in type 1 and type 2 diabetes by inhibition of intestinal glucose absorption. British Journal of Nutrition. 96(1):131-137, 2006. [xxxvii] Galisteo, M., et al. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. Journal of Nutrition. 135(10):2399-2404, 2005. [xxxviii] Khossousi, A., et al. The acute effects of a high fibre meal on postprandial blood lipids and satiety. Asia Pac J Clin Nutr. 14(Supplement):S65, 2005. [xxxix] Rigaud, D., et al. Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: a double blind study. Eur J Clin Nutr. 52(4):239-245, 1998. [xl] Matheson, H. B., et al. Cholesterol 7 alpha-hydroxylase activity is increased by dietary modification with psyllium hydrocolloid, pectin, cholesterol and cholestyramine in rats. Journal of Nutrition. 125(3):454-458, 1995. [xli] Galisteo, M., et al. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. Journal of Nutrition. 135(10):2399-2404, 2005. [xlii] Marteau, P., et al. Digestibility and bulking effect of ispaghula husks in healthy humans. Gut. 35(12):1747-1752, 1994. Monograph: Plantago ovata (Psyllium). Alternative Medicine Review. 7(2), 2002. [xliii] Obata, K., et al. Dietary fiber, psyllium, attenuates salt-accelerated hypertension in stroke-prone spontaneously hypertensive rats. Journal of Hypertension. 16(12 Part 2):1959-1964, 1998. [xliv] References source credit to In-Tele-Health © 2008 (from Hyperhealth Pro CD-ROM) |
![]() |
|||
|
|||
![]() |
|||
